Atlas Trials

Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia

Clinical trial NCT02828592 · RECRUITING

Trial details

NCT number
NCT02828592
Sponsor
Northside Hospital, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Severe Aplastic Anemia
Start date
2016-09-09
Primary completion
2027-08-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.